20,280 resources
By Version
By Realm
Start Prev Rows 400 - 600 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.18 | High Intensity Statin Therapy/Branded | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.268 | HPV Negative Results | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.27 | Non pharmacologic treatments for chronic pain ICD10PCS | active | 2024-06 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.298 | Cervical Cytology Test | active | 2023-08 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.299 | HPV 16 Tests | active | 2023-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.300 | HPV 18 Tests | active | 2023-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.305 | Counseling for Physical Activity CPT | active | 2024-01 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.306 | Counseling for Physical Activity ICD10CM | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.322 | Test 123 | active | 2025-01 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.34 | Opioid pain medications | active | 2023-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain | active | 2023-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.40 | Suicide attempt | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.42 | Naloxone and Nalmefene medications | active | 2024-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.43 | Benzodiazepine medications | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.44 | Stool softeners and laxatives | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.47 | Anxiety | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.48 | Anxiety | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.50 | Sleep disordered breathing | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.52 | Anxiety | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.54 | Adjuvant pain medications | active | 2023-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.6 | Non essential Hypertension ICD9CM | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.7 | Non essential Hypertension ICD10CM | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral | active | 2023-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.87 | Fasting Plasma Glucose | active | 2023-05 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.88 | Waist Circumference | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.9 | Hypertension | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.92 | First Degree Family Member | active | 2024-06 | us | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.94 | Glucose Tolerance Test Results | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) | active | 2025-05 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.558 | Acute Cluster Headache Medication (RXNORM) | active | 2025-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.559 | Long Term Preventive Medication for Cluster Headache | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.569 | Migraine Preventive Medication | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.601 | Acute Migraine Attack Medication | active | 2025-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.605 | NSAID OTC Migraine Attack Medication | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.606 | NSAID Prescribable Migraine Attack Medication | active | 2025-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine | active | 2023-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.642 | No pain with headache | active | 2023-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.643 | Antiplatelets | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.644 | Anticoagulants | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.645 | Statin Medications | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.651 | Galcanezumab (RxNorm) | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.652 | Lithium (RxNorm) | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.653 | Verapamil | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.654 | Long term preventive medications for cluster headache | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.655 | Short term preventive medication for cluster headache | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.656 | Zolmitriptan | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.657 | Sumatriptan | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.658 | Dihydroergotamine | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.659 | Acute cluster headache medication | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.661 | Short term preventive treatment for cluster headache | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.663 | Migraine diagnosis (ICD) | active | 2025-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.664 | Prescribable NSAIDs and Acute Migraine Attack Medication | active | 2025-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.103 | Abnormal Presentation | active | 2023-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation | active | 2021-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.130 | Respiratory Rate | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation | active | 2024-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton | active | 2021-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery | active | 2021-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy | active | 2021-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.38 | General Or Neuraxial Anesthesia | active | 2021-02 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors | active | 2023-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.55 | Oxytocin | active | 2021-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.56 | Dinoprostone | active | 2025-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.58 | Delivery Procedures | active | 2021-06 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.59 | Delivery Procedures | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.67 | PCI | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.68 | Endotracheal Intubation | active | 2018-03 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation | active | 2025-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.98 | Delivery of Singleton | active | 2021-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton | active | 2021-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED | active | 2024-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.241 | Schedule II, III and IV Opioid Medications | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.242 | Opioid Use Disorder | active | 2024-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder | active | 2024-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.265 | Inpatient, Emergency, and Observation Locations | active | 2022-07 | us | cdc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.269 | Medications for Opioid Use Disorder (MOUD) | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.274 | NHSN Inpatient Encounter Class Codes | active | 2024-04 | us | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.277 | Emergency Department Location | active | 2024-04 | us | cdc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.278 | Emergency Department Treatment Location | active | 2025-02 | us | cdc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.283 | Emergency Department Location | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.284 | Emergency Department Location | active | 2024-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders | active | 2024-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.286 | Decision to Transfer | active | 2024-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices | active | 2022-10 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.10 | Breastfeeding | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia | active | 2021-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis | active | 2017-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.107 | Low Intensity Statin Therapy | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.12 | Liver Disease | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.19 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.22 | Liver Disease ICD9 | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.37 | Stable and Unstable Angina | active | 2025-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.39 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.41 | Ischemic Heart Disease or Related Diagnoses | active | 2025-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.42 | Liver Disease | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.43 | Liver Disease | active | 2021-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.501 | Overweight or Obese | active | 2025-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.502 | Overweight or Obese | active | 2018-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.512 | Elevated Blood Pressure Reading | active | 2019-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension | active | 2019-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.515 | Bariatric Procedures | active | 2024-02 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.517 | Age related macular degeneration intermediate dry | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.518 | Ophthalmologist visit | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.519 | Posterior vitreous detachment (PVD) | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.521 | Ophthalmoscopic exam | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.523 | Opthalmoscopic exams with Scleral Depression | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.526 | Retina Ultrasound | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.529 | Vitreous hemorrhage | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.536 | Macula examination | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.539 | Fluorescein angiography | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.541 | Optical coherence tomography (OCT) | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.542 | Intravitreal injection | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.543 | Bevacizumab injection | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.544 | Ranibizumab injection | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.545 | Aflibercept injection | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.552 | Uveitis | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.553 | Uveitis | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.554 | Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.555 | Macular edema | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.556 | Corticosteroids for Injection | active | 2024-06 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.557 | Corticosteroids for Injection | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.560 | Tonometry | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.561 | Intraocular pressure | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.571 | Retinal Vein Occlusion Related Macular Edema | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage | active | 2020-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.582 | Corticosteroids for Injection | active | 2020-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.583 | Endophthalmitis in the Right Eye | active | 2020-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.584 | Endophthalmitis in the Left Eye | active | 2020-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.585 | Panophthalmitis in the Right Eye | active | 2020-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.586 | Panophthalmitis in the Left Eye | active | 2020-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.587 | Lost to follow up | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.588 | Uveitis | active | 2020-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.610 | Scleral depressed exam | active | 2020-03 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.615 | Physical Disability | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.616 | Financial difficulty | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings | active | 2020-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam | active | 2020-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.629 | Post operative follow up | active | 2020-07 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.67 | Breastfeeding | active | 2017-05 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses | active | 2021-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.73 | Breastfeeding | active | 2021-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia | active | 2023-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.89 | Rhabdomyolysis | active | 2017-05 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care | active | 2019-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.91 | Familial Hypercholesterolemia | active | 2021-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.93 | Hypercholesterolemia ICD 9 | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.97 | High Intensity Statin Therapy | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.98 | Moderate Intensity Statin Therapy | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests | active | 2025-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.51 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.10 | ARBs (Angiotensin Receptor Blockers) | active | 2024-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1000 | OIA_V2_GLP1s_RxNorms | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1001 | OIA_V2_PCSK9s_RxNorms | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1002 | OIA_RFs_Secondary_Prevention_ICD10 | active | 2025-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1004 | OIA_RFs_Secondary_Prevention_CPT | active | 2025-02 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT | active | 2025-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1006 | OIA_Asthma_COPD_Combo_Meds | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1007 | OIA_Asthma_COPD_Combo_Meds_SABA_SAMA | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1008 | OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS | active | 2025-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions | active | 2025-02 | us | sct |